As of 2025-04-29, the Relative Valuation of Kaleido Biosciences Inc (KLDO) is (2,082.47) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.29 USD, the upside of Kaleido Biosciences Inc based on Relative Valuation is -718192.5%.
The range of the Relative Valuation is (1,796.21) - (2,162.33) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.6x - 17.6x | 16.8x |
| Forward P/E multiples | 14.6x - 18.2x | 17.2x |
| Fair Price | (1,796.21) - (2,162.33) | (2,082.47) |
| Upside | -619481.3% - -745730.0% | -718192.5% |
| Date | P/E |
| 2025-04-21 | -0.00 |
| 2025-04-17 | -0.00 |
| 2025-04-15 | -0.00 |
| 2025-04-14 | -0.00 |
| 2025-04-10 | -0.00 |
| 2025-04-09 | -0.00 |
| 2025-04-04 | -0.00 |
| 2025-04-03 | -0.00 |
| 2025-04-02 | -0.00 |
| 2025-04-01 | -0.00 |
| 2025-03-31 | -0.00 |
| 2025-03-28 | -0.00 |
| 2025-03-25 | -0.00 |
| 2025-03-24 | -0.00 |
| 2025-03-20 | -0.00 |
| 2025-03-18 | -0.00 |
| 2025-03-17 | -0.00 |
| 2025-03-14 | -0.00 |
| 2025-03-13 | -0.00 |
| 2025-03-10 | -0.00 |
| 2025-03-05 | -0.00 |
| 2025-03-03 | -0.00 |
| 2025-02-27 | -0.00 |
| 2025-02-26 | -0.00 |
| 2025-02-24 | -0.00 |
| 2025-02-21 | -0.00 |
| 2025-02-20 | -0.00 |
| 2025-02-19 | -0.00 |
| 2025-02-18 | -0.00 |